
Biosecure Act Excluded from Defense Bill, Boosting Chinese Biotech
Negotiators on a key US defense bill decided not to include the Biosecure Act, which would have blacklisted five Chinese-linked biotechnology firms from federally funded research and contracts. Despite earlier support from the House and a bipartisan group in the Senate, senior House Democrats objected to naming specific companies in the legislation, resulting in a win for the Chinese biotech firms.
